Missense mutations in  cause autosomal dominant congenital nonprogressive spinocerebellar ataxia by unknown
Huang et al. Orphanet Journal of Rare Diseases 2012, 7:67
http://www.ojrd.com/content/7/1/67RESEARCH Open AccessMissense mutations in ITPR1 cause autosomal
dominant congenital nonprogressive
spinocerebellar ataxia
Lijia Huang1, Jodi Warman Chardon2, Melissa T Carter3, Kathie L Friend4, Tracy E Dudding5,6,
Jeremy Schwartzentruber7, Ruobing Zou8, Peter W Schofield9, Stuart Douglas1, Dennis E Bulman8,10†
and Kym M Boycott1,2*†Abstract
Background: Congenital nonprogressive spinocerebellar ataxia is characterized by early gross motor delay,
hypotonia, gait ataxia, mild dysarthria and dysmetria. The clinical presentation remains fairly stable and may be
associated with cerebellar atrophy. To date, only a few families with autosomal dominant congenital
nonprogressive spinocerebellar ataxia have been reported. Linkage to 3pter was demonstrated in one large
Australian family and this locus was designated spinocerebellar ataxia type 29. The objective of this study is to
describe an unreported Canadian family with autosomal dominant congenital nonprogressive spinocerebellar ataxia
and to identify the underlying genetic causes in this family and the original Australian family.
Methods and Results: Exome sequencing was performed for the Australian family, resulting in the identification of
a heterozygous mutation in the ITPR1 gene. For the Canadian family, genotyping with microsatellite markers and
Sanger sequencing of ITPR1 gene were performed; a heterozygous missense mutation in ITPR1 was identified.
Conclusions: ITPR1 encodes inositol 1,4,5-trisphosphate receptor, type 1, a ligand-gated ion channel that mediates
calcium release from the endoplasmic reticulum. Deletions of ITPR1 are known to cause spinocerebellar ataxia type
15, a distinct and very slowly progressive form of cerebellar ataxia with onset in adulthood. Our study demonstrates
for the first time that, in addition to spinocerebellar ataxia type 15, alteration of ITPR1 function can cause a distinct
congenital nonprogressive ataxia; highlighting important clinical heterogeneity associated with the ITPR1 gene and
a significant role of the ITPR1-related pathway in the development and maintenance of the normal functions of the
cerebellum.
Keywords: Congenital nonprogressive spinocerebellar ataxia, Spinocerebellar ataxia type 29, Cerebellar atrophy,
ITPR1, Gene identificationBackground
The spinocerebellar ataxias (SCA) are a group of genet-
ically heterogeneous disorders characterized by slowly
progressive cerebellar dysfunction, including gait ataxia,
dysarthria and limb dyscoordination. In addition, extra
cerebellar features may be present, including cognitive* Correspondence: kboycott@cheo.on.ca
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reproduction in any medium, provided the orimpairment, ophthalmoplegia, pyramidal and extrapyr-
amidal dysfunction [1]. In contrast to the more common
autosomal dominant (AD) adult-onset SCAs, congenital
nonprogressive spinocerebellar ataxia (CNPCA) is
characterized by early motor delay and hypotonia, as
well as other typical cerebellar features. Cognitive im-
pairment may or may not be present. The clinical pres-
entation remains stable throughout the life of an
affected individual and some patients even report im-
provement in symptoms [2]. Cerebellar atrophy is often
associated with CNPCA. Families with AD CNPCA,
with and without cerebellar atrophy, have been reportedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.ojrd.com/content/7/1/67approximately ten times since 1983 [2-10]. It is quite
likely that AD CNPCA is a genetically heterogeneous
condition [2,11]. Linkage to 3pter has been demon-
strated in one large Australian family (SCA29), which
overlaps with the locus for SCA15 [2]. SCA15 is a
dominantly inherited slowly progressive cerebellar
ataxia with mid-life onset; heterozygous ITPR1 dele-
tions spanning the entire or part of the gene are
disease-causing [12-15].
The SCA29 locus overlaps with SCA15 making ITPR1
an attractive candidate gene for AD CNPCA. Using a
combination of exome and Sanger sequencing in the ori-
ginal SCA29 Australian family (Family A) and an unre-
ported Canadian family (Family C), we identified two
different missense mutations in ITPR1 that segregate
with the disease. Our study demonstrates that alterations
in ITPR1 function are the cause of AD CNPCA (SCA29)
and further highlights the important role of the ITPR1-




We used standard methods to isolate genomic DNA
from peripheral blood of the patients and their family
members. Informed consent was obtained from all par-
ticipating patients and families according to the Declar-
ation of Helsinki and the studies were approved by the
Research Ethics Boards of the Children’s Hospital of
Eastern Ontario and Women’s and Children’s Hospital,
North Adelaide.
Genotyping
Genotyping was performed using DNA samples from all
available members of Family C. The samples were ampli-
fied individually with 5 microsatellite markers (D3S4545,
D3S1537, D3S1304, D3S3630, and D3S1297), spanning
the 6.5 Mb region from 3p26.1 to 3q26.3. Haplotypes
were constructed manually, and phase was assigned
based on the minimum number of recombinants.
Mutation analysis of ITPR1
Given the size of the mapped interval and number of
genes, we used exome sequencing to analyze the critical
region in Family A. Exome capture and massively parallel
sequencing were performed at the McGill University and
Genome Quebec Innovation Centre. In brief, the Agilent
SureSelect 50 Mb All Exon Kit was used for target en-
richment. Sequencing on Illumina HiSeq2000 platform
generated >12Gbp of 100 bp paired-end data, giving
≥20x coverage of approximately 90% of the consensus
coding sequence bases. Data analysis began with the re-
moval of the adaptor sequences and trimming using the
Fastx toolkit (http://hannonlab.cshl.edu/fastx_toolkit/).Next, a custom script was used to select only those read
pairs with both mates present for further alignment.
Reads were aligned to human reference sequence (hg19)
with BWA [16], and duplicate reads were marked using
Picard (http://picard.sourceforge.net/) and excluded from
downstream analyses. Single nucleotide variants and
short insertions and deletions were called using Samtools
pileup (http://samtools.sourceforge.net/) and varFilter
[17] with the base alignment quality adjustment disabled,
and were then quality-filtered to require at least 20% of
reads supporting the variant call. Variants were anno-
tated using both Annovar [18] and custom scripts to
identify whether they affected protein coding sequence,
and whether they were represented in dbSNP131, the
1000 genomes pilot release (Nov. 2010), or in approxi-
mately 120 exomes previously sequenced at the center.
Sanger sequencing of the 58 exons and all associated
exon/intron junctions of ITPR1 in one affected individ-
ual from Family C was performed using standard
methods.
The mutation identified in each family was confirmed
to segregate as expected using Sanger sequencing. The
primer pairs used for segregation analysis of Family A
and Family C were: 5’ CTGGGTGTGAAAAACCTGCT
3’/ 5’ GCCCAGCTTAGATGCTCTGT 3’ and 5’ CAT
CAGGAAACATTGCTGCTT 3’/ 5’ AGCAGCACAAG
GAAACGTAG 3’, respectively.
Protein sequence alignment
Multiple sequence alignment was performed using
clustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
Species that were compared were: Homo sapiens
(Human; NP_001093422.2), Pan troglodytes (Chimpan-
zee; XP_003309637.1), Mus musculus (House mouse;
NP_034715.3), Rattus norvegicus (Norway rat; NP_
001007236.1), Bos Taurus (Cattle; NP_777266.1), Gallus
gallus (Chicken; NP_001167530.1), Xenopus laevis
(African clawed frog; NP_001084015.1), Danio rerio
(Zebrafish; XP_001921194.2), Metaseiulus occidentalis
(Western predatory mite; XP_003747783.1), Apis melli-
fera (Honey bee; XP_392236.4), and Clonorchis sinensis
(Oriental liver fluke; GAA48211.1).
Results
Clinical features of Family C
We identified a three-generation Canadian family with
AD nonprogressive spinocerebellar ataxia. The proband
was initially noted by her parents to have delayed sitting
at 8 months of age. When examined in the Neuroge-
netics clinic at 28 months of age, her head circumfer-
ence was 47.5 cm (25th percentile). She demonstrated
clear language delay; she was able to say 10 words, had
10 signs and followed simple commands. She had gaze-
evoked nystagmus, hypotonia, truncal titubation and
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pendently. Power, sensory, and deep tendon reflexes
were normal. On reassessment at 3.5 years of age, we
noted that while she was making developmental pro-
gress, she continued to exhibit cognitive delay, truncal
titubation and limb ataxia. An MRI of the brain at
1 year of age demonstrated mild cerebellar vermal at-
rophy (Figure 1A), with progression of cerebellar ver-
mal atrophy when the MRI was repeated at age
5 years (Figure 1B). She also developed complex partial
seizures at age 5 years, and was found to have elec-
trical status epilepticus of sleep on EEG. Her seizures
and EEG improved with anti-epileptic medications.
The proband has a clinically unaffected sister with
normal development and no ataxia. The proband’s
father, 45 years old, also demonstrated significantly
delayed gross motor milestones, walking independently





Figure 1 Neuroimaging features of Family C. A. T1 weighted sagittal M
cerebellar hypoplasia at 1 year of age. B. Demonstration of cerebellar atrop
and axial MRI of the brain of the proband’s father at 45 years of age demoand repeated two primary grades, although he com-
pleted high school and some college courses. He is
currently employed as a custodian. Physical examin-
ation demonstrated saccadic eye movements with end
range nystagmus, dysarthria, gait and limb ataxia and
intention tremor. Tone, power and deep tendon
reflexes were normal and there were no sensory defi-
cits. MRI of the brain at 45 years of age revealed dif-
fuse cerebellar atrophy (Figure 1C and 1D). The
proband’s paternal aunt ambulated independently at
4 years of age and repeated one primary grade. The
proband’s paternal grandmother was similarly affected.
All affected individuals had an unremarkable perinatal
history. The proband’s mother had no evidence of
ataxia and normal early development. However, she
was diagnosed with Landau Kleffner syndrome at age 5
years, an acquired aphasia with epilepsy. She subsequently
had full language recovery and remission of seizures.5 years oldB
D
f Family C 
he proband
Axial
RI of the brain of the proband from Family C demonstrating mild
hy in the proband at 5 years of age. C. and D. T1 weighted sagittal
nstrating diffuse cerebellar atrophy.
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In our previously reported study of Family A with
CNPCA [2], the disease locus was mapped to the ter-
minal region of chromosome 3 (D3S1304 to 3pter,
two-point lod score of 4.26), which contains the ITPR1
gene [2]. Given the significant clinical overlap between
Family C and the reported Australian family, we geno-
typed the affected and healthy family members of
Family C with 5 microsatellite makers from 3pter. Haplo-
types were constructed manually, and phase was assigned
based on the minimum number of recombinants. The
genotyping results indicated that all the affected family
members shared a common haplotype in the region con-
taining ITPR1 and one unaffected individual (II-3)
couldn’t be phased (Figure 2A). Chromosomal micro-
array analysis (Affymetrix 6.0 SNP array) of the proband
was unrevealing; specifically there was no deletion of the
ITPR1 gene.
Exome sequencing of the original SCA29 family (Family A)
Next, we wanted to determine if a mutation in ITPR1, or
another gene in the critical region, is responsible for the
SCA29 phenotype in the family from Australia [2]. We
sequenced the exome of one affected individual from the
family. The Agilent SureSelect 50 Mb All Exon Kit used
in this study includes probes that target all 14 protein
coding genes in the critical region. The mean read depth
of these genes ranged from 52X to 205X. Nearly every
base of the ITPR1 gene had more than 50X coverage
using this approach. After filtering out all the existent
variants in dbSNP and the 1000 genomes pilot release,
only one variant, a missense mutation in ITPR1
(NM_001099952.2:c.4657G >A; p.Val1553Met), was iden-
tified within this critical region. In addition, this muta-
tion was not found in 5379 exomes from the NHLBI
Exome Sequencing Project. Sanger sequencing confirmed
the segregation of the mutation with the disease in the
family (Figure 2B and Additional file 1). The Valine resi-
due at position 1553 is highly conserved among the ver-
tebrates and certain non-chordates, such as Metaseiulus
occidentalis (mites) (Figure 2C).
Sequence analysis of ITPR1 in Family C
Next, we PCR amplified and Sanger sequenced all 58
exons and the exon/intron boundaries of the ITPR1
gene in one affected individual from Family C and iden-
tified a missense mutation (NM_001099952.2:c.1804A >G;
p.Asn602Asp) (Figure 2D), which segregated with the dis-
ease phenotype in the family. This mutation was not
found in 136 controls of European descent, the 1000 gen-
omes project, or the NHLBI Exome Sequencing Project
(5379 exomes). Moreover, the Asparagine at position 602
is a highly conserved residue among both vertebrates and
non-chordates (Figure 2E).Discussion
We describe two families with AD congenital nonpro-
gressive spinocerebellar ataxia caused by missense muta-
tions in ITPR1, demonstrating for the first time clinical
heterogeneity associated with alterations of this gene.
Cerebellar atrophy has been identified as an early feature
of this disorder and was observed in the proband of
Family C at 28 months. Interestingly, serial imaging of
the proband from this family demonstrates that, at least
in this case, the cerebellar atrophy continues to progress
(Figure 1A and 1B). Given that she continues to slowly
make developmental gains we would classify her presen-
tation as a clinically nonprogressive ataxia. In Family A,
five members reported improvement in ataxia [2].
Amelioration in ataxia has been reported in an add-
itional series of patients with CNPCA [3,7,8,19]. The
mechanism by which patients demonstrate an improve-
ment in ataxia is unknown but may result from early
adaptation to the cerebellar dysfunction, particularly in
instances where the atrophy is nonprogressive. In
addition to cerebellar ataxia and cognitive impairment,
the proband of Family C had epilepsy. There have been
reports of congenital cerebellar dysfunction associated
with electrical status of slow wave sleep, as seen in the
proband of this study [20]. It is unclear if the occurrence
of seizures in the proband is related to the ITPR1 muta-
tion; this possible association will be better understood
as further patients are identified.
SCA15 and SCA29 are distinctly different disorders;
clinical features distinguishing SCA15 from SCA29 in-
clude the age of onset (adulthood versus congenital),
clinical progression (progressive vs static) and the occur-
rence of mild intellectual disability (present in SCA29).
SCA15 has been reported to be the most common non-
trinucleotide repeat SCA in central Europe accounting
for 8.9% of SCA families negative for common SCA re-
peat expansions [21]. Deletions of the ITPR1 gene are
the underlying genetic cause of almost all cases of
SCA15 [12-15,21]. So far, only one family with adult-
onset SCA has been reported to harbor a missense mu-
tation in ITPR1 [13] and the Ca2+ release properties of
this mutant ITPR1 are comparable with wild type
ITPR1: therefore, functional pathogenicity of this change
has not been established or there is another mechanism
for the disease process [22]. The mechanism by which
different mutations in ITPR1 can cause two different
phenotypes, SCA15 and SCA29, is unclear.
The ITPR1 gene encodes type 1 inositol 1,4,5-trispho-
sphate (IP3) receptor, a ligand-gated Ca
2+ channel on the
endoplasmic reticulum membrane. Upon binding to IP3,
ITPR1 channels release Ca2+ into the cytoplasm produ-
cing complex Ca2+ signals that are involved in various
cellular processes [23]. ITPR1 functions as a homotetra-
mer or heterotetramer with type 2 or type 3 inositol
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Figure 2 Missense mutations in ITPR1 in two families with autosomal dominant congenital nonprogressive spinocerebellar ataxia. A.
Pedigree of Family C with AD CNPCA demonstrating segregation of the haplotype at 3pter with the disease (markers boxed in black). Affected
individuals are represented by black symbols. A diagonal line indicates a deceased individual. Black arrow indicates the proband. B. Exome
capture and massively parallel sequencing of III-6 from Family A identified a heterozygous mutation in ITPR1 (NM_001099952.2:c.4657G >A;
p.Val1553Met) which was confirmed by Sanger sequencing. Sequence traces from an unaffected (top) and an affected member (bottom) of
Family A show the heterozygous mutation c.4657G>A (red) in the affected individual. C. Multiple sequence alignment of Homo sapiens ITPR1
against its orthologues from ten other species (vertebrates are labeled in black; non-chordates are labeled in blue) was performed using ClustalW.
The mutated amino acid (residue 1553 in the human sequence) is boxed in red. D. Sequence traces from an unaffected (top) and affected
member (bottom) of Family C show the heterozygous mutation c.1804A >G (red) in the affected individual. E. Multiple sequence alignment of
Homo sapiens ITPR1 against its orthologues from ten other species (vertebrates are labeled in black; non-chordates are labeled in blue) was
performed using ClustalW. The mutated amino acid (residue 602 in the human sequence) is boxed in red.
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abundant isoform in the central nervous system, particu-
larly enriched in cerebellar Purkinje cells [23]. In almost
all SCA15 cases, partial or complete deletion of ITPR1
gene suggests that ITPR1 haploinsufficiency is the pre-
dominant mechanism. The missense mutations in ITPR1that cause SCA29 are localized to the coupling/regula-
tory domain of ITPR1. The coupling/regulatory domain,
containing protein phosphorylation sites, a proteolytic
cleavage site, ATP binding sites, and binding sites for
numerous proteins, modulates ITPR1 function by inte-
grating other signaling pathways [24]. Asn602 is located
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within the binding domain for CA8. Interestingly, both
IRBIT and CA8 are competitors of IP3 for binding to
ITPR1. Mutations in CA8 cause a recessive form of con-
genital ataxia associated with mild intellectual disability
[25]. The only known function of CA8 is that it inhibits
IP3 binding to ITPR1 [26], therefore ITPR1 may be more
sensitive to IP3 in CA8-deficient patients and the disease
would result from dysregulation of the channel. Thus, it
is likely that the two SCA29-causing missense mutations
reported here affect the normal regulation of ITPR1.
Dysfunction of the ITPR1-mediated Ca2+ signaling
pathway is implicated in the development of several
types of late-onset ataxia in addition to SCA15. The ex-
pression of Itpr1, among other neuronal genes, is down-
regulated in the transgenetic SCA1 mouse models
expressing mutant ataxin-1 [27]. Mutant ataxin-2 and
ataxin-3, but not the wild-type proteins, can interact
with ITPR1 and sensitize its IP3-induced Ca
2+ release
causing disruption of calcium signalling in the mutant
neurons [28,29]. Itpr1 also plays an important role in
embryonic development; the majority of Itpr1 null mice
die prenatally and those which survive to birth display
severe ataxia and epilepsy [30]. Similar symptoms were
seen in two spontaneous Itpr1 mutant mouse models
[12,31]. Interestingly, the heterozygous null mice grow
normally but present with late-onset motor discoordina-
tion [32]. These results implicate an essential role of
ITPR1-dependent signaling in both cerebellar develop-
ment and maintenance.
Conclusions
In summary, our study demonstrates that missense
mutations in ITPR1 cause AD congenital nonprogressive
spinocerebellar ataxia (SCA29) and further emphasizes
the importance of the ITPR1-dependent pathway in the
development and maintenance of the normal functions
of cerebellum. This finding expands the phenotypic
spectrum caused by ITPR1 mutations and will facilitate
molecular diagnosis for patients with congenital nonpro-
gressive spinocerebellar ataxia.
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